1628945-93-6
Chemical Structure
BPN-14136
- CAS No.: 1628945-93-6
- Formula:C20H20F3N3O2
- Molecular Weight:391.39
InChIKey: XODSGAMMDBEEFN-ZSOGYDGISA-N
SMILES: FC(F)(C1=C(C=CC=C1)[C@@H]2C[C@@]3([H])[C@@](CN(C4=NC(C)=CC(C(O)=O)=N4)C3)([H])C2)F
Biological Activity: BPN-14136 is an orally effective retinol-binding protein 4 (RBP4) inhibitor. BPN-14136 inhibits the binding of retinol to RBP4 with an IC50 of 12.8 nM. BPN-14136 inhibits retinol-dependent RBP4-transthyretin interaction (IC50 = 43.6 nM) and reduces circulating plasma RBP4 levels in vivo. BPN-14136 decreases the formation of cytotoxic bisretinoids in retinal pigment epithelial cells. BPN-14136 can be used for the research of atrophic age-related macular degeneration and Stargardt disease[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BPN-14136 | BPN-14136 is an orally effective retinol-binding protein 4 (RBP4) inhibitor. BPN-14136 inhibits the binding of retinol to RBP4 with an IC50 of 12.8 nM. BPN-14136 inhibits retinol-dependent RBP4-transthyretin interaction (IC50 = 43.6 nM) and reduces circulating plasma RBP4 levels in vivo. BPN-14136 decreases the formation of cytotoxic bisretinoids in retinal pigment epithelial cells. BPN-14136 can be used for the research of atrophic age-related macular degeneration and Stargardt disease. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
